Samanta S. Gündel is a pharmacist and PhD researcher with expertise in pharmaceutical nanotechnology, drug delivery systems, and cancer therapy. She holds a PhD in Pharmaceutical Sciences from the Federal University of Rio Grande do Sul (UFRGS, Brazil). Her research focuses on the development and characterization of organic nanoparticles for targeted drug delivery, with a special emphasis on organic nanoparticles and nanocarriers with functionalized surfaces for anticancer applications. She has experience in pharmaceutical formulation development, physicochemical characterization, analytical method validation, surface modification, drying techniques, cell culture, and the in vitro, ex vivo, and in vivo preclinical evaluation of nanomedicines. Her current research interests include precision nanomedicine, active tumor targeting, and innovative strategies to overcome drug resistance and improve therapeutic efficacy.